DrugDashboards

Zolpidem Tartrate

Zolpidem Tartrate · ZOLPIDEM TARTRATE 6.25 mg/1 · Tablet, Film Coated, Extended Release · Oral · Sun Pharmaceutical Industries, Inc.

NDC 47335-0307-88 · 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 18% over the past year, to $0.1065 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.1065per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$20.50per dosage unitgross, before rebates — matched by drug name · 2024
  • Part D point of sale (median)$0.2784per unitnegotiated price across 1,520 plans — before rebates · Apr 1, 2026
  • Medicaid generic ceiling (FUL)$0.2329per TABweighted avg manufacturer price $0.1331 · Aug 1, 2026219% of what pharmacies pay — higher than 90% of drugs with this benchmark

Medicare Part D

All Part D pricing →
ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$0.2784per unit
middle half $0.2638$0.4018 · 1,520 plans · Apr 1, 2026
Est. net of rebates
≈ $0.2784
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
28%of plans cover it
tier 2 · prior auth 6% · step therapy 0% · qty limit 98%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 9 quarters since 2024.

NADAC price per unit

$0$1.00$2.00Dec 2017Sep 2026$0.1065
104 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$3.19
#90 count
$9.58

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$36,473
2,873 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

5Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 5 active manufacturers+5

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for zolpidem tartrate (oral solid) in the next 90 days

sole-source market · price up 1% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA204170
TE code
AB
Approval date
Jan 24, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · CompletedJan 18, 2024
    SUN PHARMACEUTICAL INDUSTRIES INCCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
  • Class II · CompletedJan 18, 2024
    SUN PHARMACEUTICAL INDUSTRIES INCCGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Manufacturers of Zolpidem Tartrate (Tablet, Film Coated, Extended Release)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackZOLPIDEM TARTRATE 12.5 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCZOLPIDEM TARTRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.ZOLPIDEM TARTRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPZOLPIDEM TARTRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.ZOLPIDEM TARTRATE 12.5 mg/1Jul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.ZOLPIDEM TARTRATE 6.25 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCZOLPIDEM TARTRATE 6.25 mg/1Jul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Zolpidem Tartrate — NDC 47335-0307-88," retrieved September 3, 2026, https://drugdashboards.com/drug/47335030788.

Free to cite with attribution — see how the data is put together.